|Videos|August 24, 2021

Dr. Victoria Scott on managing recurrent UTIs

Author(s)Urology Times staff

In this video, Victoria C. Scott, MD, discusses the alternatives to immediate antibiotic treatments for recurrent urinary tract infections and how practitioners can reassure their patients through education on UTIs. Scott is a urologist at Cedars-Sinai Medical Center, Beverly Hills, California.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Related Content

Jessica Yih, MD, highlights data on testosterone therapy in women

ByJessica M. Yih, MD

August 11th 2026

Pearls & Perspectives: Wearable Technology and the Future of Sexual Health, With Elliot Justin, MD

ByAmy M. Pearlman, MD,Larry Lipshultz, MD,Elliot Justin, MD, FACEP

August 5th 2026

Pearls & Perspectives: Bridging Gaps in Functional Urology Care, With Diane Newman, DNP, FAAN, BCB-PMD, and Stuart Hart, MD, MBA, MS

ByAmy M. Pearlman, MD,Larry Lipshultz, MD,Diane K. Newman, DNP, FAAN, BCB-PMD,Stuart Hart, MD, MBA, MS

July 7th 2026

Pearls & Perspectives: The Power of Advocacy in Sexual Medicine, With Rachel Rubin, MD

ByAmy M. Pearlman, MD,Larry Lipshultz, MD,Rachel Rubin, MD

June 23rd 2026

Pearls & Perspectives: The Evolving Landscape of Female Pelvic Health, With Annah J. Vollstedt, MD

ByAmy M. Pearlman, MD,Annah J. Vollstedt MD

June 9th 2026

Latest CME

Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care

Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Nerina McDonald, MSPAS, PA-C; Scott T. Tagawa, MD, MS, FACP, FASCO

Ready for Radioligand Therapy? Patient Selection and Sequencing Simplified

Ready for Radioligand Therapy? Patient Selection and Sequencing Simplified

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO

Radioligand Therapy 101: The Science Behind the Strategy

Radioligand Therapy 101: The Science Behind the Strategy

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO

Enhancing Prostate Cancer Outcomes – The Role of PSMA and Targeted Treatment Strategies

Enhancing Prostate Cancer Outcomes – The Role of PSMA and Targeted Treatment Strategies

Ana Kiess, MD, PhD; Erin Grady, MD, CCD, FACNM, FSNMMI; Himanshu Nagar, MD, MS; Scott T. Tagawa, MD, MS, FASCO, FACP

Burst CME™: Recognizing Lupus Nephritis—From Timely Diagnosis to Appreciating the Underlying Mechanisms of Disease

Burst CME™: Recognizing Lupus Nephritis—From Timely Diagnosis to Appreciating the Underlying Mechanisms of Disease

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

Trending on Urology Times

CMS' 2027 PFS proposed rule: Modifier -25 cuts, G2211 overhaul loom

The UroOnc Minute: Cribriform Histology in Prostate Cancer, With Tyler Seibert, MD, PhD

Rezūm shows greater 1-year BPH symptom relief vs pharmacotherapy

FDA grants breakthrough therapy, fast track designations to kidney cancer imaging agent

Kari Tikkinen, MD, PhD, discusses POISE-3 findings on tranexamic acid in urologic surgery